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Studies of the cellular immunology and protein
structure of human and mouse CD1 proteins reveal
these to be a family of antigen-presenting molecules
that allow T cells to recognize lipid and glycolipid
antigens of microbial pathogens.
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In an immune response, the recognition of protein anti-
gens by T cells requires a process known as antigen pre-
sentation, in which foreign proteins are broken down into
peptide fragments within antigen-presenting cells and
then displayed on the surface of these cells, where they
can be recognized by T-cell antigen receptors. This
process of presentation requires the class I and class II
proteins encoded by genes of the major histocompatibility
complex (MHC) that are specialized for binding and dis-
playing peptide antigens. It has recently become clear,
however, that T cells can also specifically recognize lipid
and glycolipid antigens derived from pathogenic bacteria.
How these non-protein antigens are recognized is becom-
ing clear from studies of a family of proteins, known as
CD1 proteins, which are now recognized to be antigen-
presenting molecules, distinct from the MHC proteins,
that provide a unique solution to the problem of display-
ing particular types of foreign antigen to T cells.
CD1 proteins appear to be present in most or all
mammals, but so far they have been extensively studied
only in humans and mice [1,2]. The human CD1 system
consists of five closely linked, non-polymorphic genes that
map to chromosome 1, and are thus unlinked to the MHC
on chromosome 6. Four of the five CD1 genes are known
to encode protein products — related, but distinct, CD1
isoforms known as CD1a, CD1b, CD1c and CD1d.
Sequence comparisons show that these proteins can be
classified into two separate groups: CD1a, CD1b and
CD1c form group 1, and the significantly more divergent
CD1d defines group 2. The mouse CD1 system is less
complex, with only two, very closely related CD1 genes
encoding the mCD1.1 and mCD1.2 proteins, both of
which appear to be homologues of human CD1d.
CD1 proteins show striking structural similarities to MHC
class I proteins. Thus, like MHC class I proteins, CD1
proteins consist of a transmembrane glycoprotein — the
heavy chain — associated non-covalently with b2
microglobulin (b2m; Figure 1). Furthermore, the extracel-
lular portions of CD1 heavy chains are composed of three
domains, designated a1, a2 and a3, which are similar in
size to the three analogous domains of MHC class I heavy
chains. At the amino-acid level, limited but significant
homology — up to about 30% identity in a2 and a3, but
undetectable in the a1 domain — is seen between the
extracellular domains of CD1 proteins and the correspond-
ing domains of MHC class I and II proteins. Thus the
CD1 proteins clearly arose from the same ancestral lineage
Figure 1
The subunit structures and domain organization of MHC class I
(MHCI), MHC class II (MHCII) and CD1 antigen-presenting molecules,
and their pathways of intracellular transport. The CD1b protein
localizes prominently to endosomes, including the same intracellular
compartments that are rich in MHCII molecules (MHCII compartments,
MIICs). Preliminary evidence indicates that several, although probably
not all, of the different CD1 isoforms show a similar pattern of
intracellular localization. As indicated by the arrows, the pathway taken
by CD1 proteins to the endosomes may involve recycling from the
plasma membrane, as opposed to that taken by MHCII proteins, which
are mainly targeted directly to the endosomal system from the trans-
Golgi network. MHCI molecules are not found in endosomes, as they
traffic directly to the cell surface via the default secretory pathway.
α2
α3 β2m
α2 α1
α3 β2m
β1
β2
α1
α2
α1
MHC
class I
CD1 MHC
class II
Endosome
(MIIC)?
MHCI
MHCII
Golgi
CD1
ER
© 1997 Current Biology
as the MHC proteins, but the two protein families
diverged long ago and now differ markedly in sequence.
Direct evidence that CD1 proteins are also functionally
similar to MHC proteins, in that they can present
antigens, has come mainly from studies of human group 1
CD1 proteins. In man, CD1a, CD1b and CD1c are promi-
nently expressed on specialized antigen-presenting cells
— most notably dendritic cells found in a wide variety of
tissues — and are required for the presentation of antigens
from mycobacteria to certain T cells ([3,4] and our unpub-
lished data). A most remarkable and surprising finding
came with the identification of the specific antigens recog-
nized by these T cells: these antigens turned out not to be
chemically related to the usual peptide antigens recog-
nized by conventional MHC-restricted T cells, but
instead proved to be various lipid and glycolipid compo-
nents of the bacterial cell wall [5,6].
The first CD1-presented antigens to be purified to
homogeneity were identified as mycolic acids, members of
a family of branched long-chain fatty acids found abun-
dantly in mycobacterial cell walls, with a general structure
distinct from that of lipids from higher eukaryotes. Analy-
ses of other mycobacterial antigens recognized by CD1-
restricted T cells have confirmed this general theme,
identifying the inositol-containing phospholipids lipoarabi-
nomannan and phosphatidylinositol mannosides as anti-
gens presented by CD1b (Figure 2). Although
hydrophobic peptides isolated from a random peptide
phage-display library have been found to bind with high
affinity to the mouse CD1d homologue and sensitize CD1-
expressing target cells for lysis by specific cytotoxic T lym-
phocytes [7], all of the naturally occurring CD1-presented
antigens described so far appear to be lipids or glycolipids.
While the full range of natural antigens that can be
presented by CD1 proteins is not yet known, a common
structural motif for CD1-presented antigens is suggested by
the currently available data. All of the lipid and glycolipid
antigens identified so far have a branched or dual acyl chain
portion which imparts marked hydrophobicity to one end of
the molecule; the other end contains various hydrophilic
groups, such as carbohydrate residues, polar hydroxyls or a
charged carboxylate. The effects of chemically modifying
the antigens have confirmed that both the hydrophilic and
hydrophobic ends of these structures are involved in their
presentation to T cells and recognition as antigens [5,6].
As it is unlikely that the acyl chains of these antigens can
remain exposed to solvent in an aqueous environment,
these findings suggest a model for lipid–antigen binding
by CD1, in which the hydrophobic moiety of the antigen
forms a stable association with a putative hydrophobic
binding-site in the CD1 protein. Indeed, the amino-acid
sequences of the a1 and a2 domains of all CD1 proteins
are unusually hydrophobic when compared to other
antigen-presenting molecules, indicating that there is the
potential for formation of a lipid-binding cavity in the
three-dimensional structure of the folded protein [2].
This expectation has now essentially been validated with
the recent solution of the three-dimensional structure of a
mouse CD1 protein (mCD1.1) by X-ray crystallography
[8]. Although the structure is strikingly similar to an MHC
class I molecule in many aspects of its overall extracellular
form, it is substantially different in the region correspond-
ing to the peptide-binding groove of an MHC molecule.
Although narrow at its opening, the CD1 groove descends
into a deep cavity lined almost entirely by nonpolar or
hydrophobic amino-acid sidechains. The multiple distinct
pockets for anchoring peptide sidechains seen in the
peptide-binding grooves of all MHC molecules seem to
merge into just two large pockets in the CD1 structure. At
least one end of the CD1 hydrophobic cavity appears to be
Dispatch R509
Figure 2
Structures of CD1-presented lipid antigens. Note the presence of a
hydrophobic component, composed of two acyl chains (phosphatidyl-
inositol mannoside) or a single branched acyl chain with two tails
(mycolic acids). The mycolic acid shown is characteristic of the keto
variety found in M. tuberculosis, containing a single cyclopropane ring
and a keto substitution in the longer branch of the asymmetric
branched acyl chain. Both antigens also contain a hydrophilic portion,
containing multiple charged or polar groups.
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closed and, despite its large surface area, it has little capac-
ity for the hydrogen-bonding interactions that are promi-
nent between peptides and MHC class I and II proteins. 
These features argue against CD1 having a typical
peptide-binding function, and instead appear to indicate
the presence of a site that is ideally suited to the binding
of markedly hydrophobic ligands, such as the lipid and gly-
colipid bacterial antigens that have been shown to be pre-
sented to human CD1-restricted T cells. The crystal
structure of this CD1 protein leads us to propose that the
lipid tails of antigens such as mycolic acids and lipoara-
binomannan anchor in the hydrophobic cavity of CD1,
leaving the hydrophilic glycan-containing and oxygen-con-
taining groups protruding from the CD1 molecule and
accessible for interactions with T-cell receptors (Figure 3).
Interestingly, the mouse CD1 structure is described as
containing a poorly defined unbranched density within the
pockets of the deep hydrophobic groove [8]. Although this
apparent bound material has not been precisely identified,
its branched structure strongly suggests that it is not a
peptide, and might in fact represent a bound acyl chain.
An important future advance will be the solution of struc-
tures of CD1 proteins crystallized in the presence of
bound lipid antigens of known structure, so as to visualize
the protein–lipid interaction directly.
Another aspect of this model for CD1 function that
remains to be resolved is the problem of antigen loading,
that is, the mechanism by which lipid antigens are inserted
into the hydrophobic cavity of the CD1 protein. Prelimi-
nary clues to how this may be accomplished come from
studies of the intracellular transport and subcellular local-
ization of CD1b. This protein contains a targeting motif
within its short cytoplasmic tail that directs it to acidic
endosomal compartments, including those compartments
in which MHC class II molecules are loaded with peptide
antigens before being transported to the membrane [9,10].
Preliminary studies suggest that an acidic environment
may induce conformational changes in CD1b, leading to
greater accessibility of the hydrophobic binding-site to
antigen (R.L. Modlin, personal communication). Further-
more, these compartments are known to harbor an exten-
sive array of degradative enzymes, raising the possibility
that enzymatic processing of lipids and glycolipids may
occur either before or after their binding to CD1. In fact,
for the large glycolipid antigen lipoarabinomannan, it
appears likely that the carbohydrate moiety is extensively
cleaved within acidic endosomes before it is presented on
the cell surface by CD1b [6]. Whether similar mechanisms
will apply for other forms of human CD1 or for the murine
CD1 molecules remains to be determined.
What is the role of CD1-restricted, lipid-antigen-specific T
cells in the overall immune response? In humans, studies
have so far emphasized the potential role of these T cells
in mycobacterial infections. Group 1 CD1 proteins are
highly expressed on dendritic cells that infiltrate cutaneous
granulomas in patients with Mycobacterium leprae infections
who show effective immunity to this pathogen (S.A.P., P.
Sieling and R.L. Modlin, unpublished observations). Fur-
thermore, in vitro CD1-restricted T cells have been shown
to secrete proinflammatory cytokines [6], and also to kill
mycobacterially-infected mononuclear phagocytes (S.
Stenger and R.L. Modlin, personal communication).
More definitive studies on the role of the CD1 system in
protective immunity are likely to involve animal models.
In this regard, it is noteworthy that CD1-deficient mice
generated by targeted gene disruption of both murine
CD1 genes have recently been reported [11]. Studies in
these animals so far have been limited to the analysis of a
specialized subset of T cells that express a cell surface
C-type lectin molecule called NK1. These NK1+ T cells
are activated by recognition of mouse CD1 molecules, and
respond by rapid secretion of large quantities of cytokines,
Figure 3
A proposed model for T-cell recognition of lipid antigen presented by
CD1. The lipid antigen is shown with its dual acyl chain tails anchored
into the hydrophobic cavity of CD1, while the hydrophilic end
protrudes from CD1 towards the solvent-exposed face of the protein
where interactions with the T-cell receptor occur.
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particularly interleukin-4 [12]. These cells are lacking
from CD1 mutant mice, and this correlates with a defect
in splenic production of interleukin-4 upon T-cell stimu-
lation under certain conditions in vivo. Perhaps more
importantly, these mice now offer an opportunity to
explore the extent of the contribution of the mouse CD1
system to immunity, including its possible role in the pre-
sentation of lipid antigens from various pathogens, such as
mycobacteria and other persistent intracellular pathogens
for which T-cell-mediated immunity is critical.
Thus, it is now clear that the CD1 system defines a new
paradigm for T-cell recognition of foreign antigens. This
unique adaptation of antigen-presenting cells represents
another remarkably sophisticated and highly evolved
approach to solving the problem of detecting microbial
invasion, and increases the range of potential T-cell anti-
gens by extending it to selected classes of microbial cell-
wall lipids and glycolipids that cannot be presented by the
MHC system. By solving the problem of how to make oil
and water mix, the CD1 system appears to have created an
interface between the hydrophilic environment in which
specific immune receptor proteins such as the T-cell
receptor are able to function efficiently, and the hydropho-
bic environment in which antigenic lipids normally reside.
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